September 20, 2012

Lance's bipartisan measure, the "Recalcitrant Cancer Research Act of 2012" (H.R. 733), would help the National Cancer Institute's efforts to improve prevention, diagnosis and treatment of cancers with high mortality rates, such as pancreatic cancer.